Precision Genetics

Precision Genetics is a biotechnology and pharmaceutical startup with a mission to leverage the power of genomics for advancing precision medicine and improving prescribing outcomes for patients. The company provides comprehensive lab and genetics testing solutions, including COVID and pharmacogenomics, to enhance overall patient outcomes. By integrating evidence-based technology and population risk analysis, Precision Genetics offers a solution that allows healthcare providers to promptly deliver personalized treatment and prevention plans. This approach not only reduces interaction and efficacy risks but also ensures the appropriate use of medications for therapies. Utilizing genetic markers, molecular data, and clinical evidence, Precision Genetics empowers busy physicians and providers to immediately develop individualized treatment and prevention plans for their patients. Moreover, the company's interactive tools enable patients to address their individual risks and treatment pathways based on their unique genetics, demographics, lifestyle, and medical conditions. Founded in 2017, Precision Genetics aims to revolutionize precision medicine by providing actionable insights and personalized approaches to healthcare. As a potential investment opportunity, Precision Genetics operates in promising sectors such as biotechnology and pharmaceuticals. However, information regarding the last investment, investors, location, and funding amount is currently unavailable, making it essential to delve deeper into the company's financial status and growth prospects. Keep an eye on Precision Genetics for its potential to drive innovation and address critical healthcare challenges through genomics and personalized medicine.